MDM2 and osteosarcoma: In a recent study of 22 low-grade osteosarcomas (3 low-grade central, 14 classic parosteal, and 5 dedifferentiated parosteal osteosarcomas), an MDM2 (12q15) amplification was revealed in 100% of the cases by fluorescence in situ hybridization.